Showing 3211-3220 of 20413 results for "".
The Impact of Positive Communication with PsA Patients
https://reachmd.com/programs/beyond-skin-deep/the-impact-of-positive-communication-with-psa-patients/10148/As physicians, we know that there are risks and benefits to all medical treatments, but how do we convey this to our PsA patients?FAQ: Automated Vitrification and Improved Pregnancy Rates
https://reachmd.com/programs/global-womens-health-academy/faq-automated-vitrification-and-improved-pregnancy-rates/9764/Dr. Alla Kalugina answers questions for the Global Women's Health Academy.Alternative Indications for In Vitro Fertilization: Do the Benefits Outweigh Risks?
https://reachmd.com/programs/what-your-patients-are-talking-about/alternative-indications-in-vitro-fertilization-benefits-outweigh-risks/8106/Dr. Brian McDonough talks about In Vitro Fertilization applications beyond traditional applicationsDigital Eye Strain: What Are the Long Term Health Implications?
https://reachmd.com/programs/primary-care-today/digital-eye-strain-what-are-long-term-health-implications/7285/On average, more than 90% of adults spend more than two hours each day using a digital device, and for 60% of the population, that daily use pattern extends beyond five hours. Regardless of the reasons why, all that time can take a toll on the eyes and lead to digital eye strain. Speaking on the heaLifestyle Intervention and Bone Quality in Older Adults with Obesity
https://reachmd.com/programs/clinicians-roundtable/program-name/39653/Imaging and Proteomics: Differentiating Neuropathic Corneal Pain from Dry Eye
https://reachmd.com/programs/eye-on-ocular-health/imaging-and-proteomics-differentiating-neuropathic-corneal-pain-from-dry-eye/37271/Triple Threat: Key Data on Simultaneous Estrogen, CDK4/6, and PI3K Inhibition in mBC
https://reachmd.com/programs/cme/Triple-Threat-Key-Data-on-Simultaneous-Estrogen-CDK4-6-and-PI3K-Inhibition-in-mBC/37335/Join Drs. Jhaveri and Kalinsky and get up to speed on the latest data on PI3K-directed therapies and their role in the treatment paradigm for HR+, HER2- mBC.Timing Matters: Influenza Vaccination Response in MS Patients on Ofatumumab
https://reachmd.com/programs/neurofrontiers/timing-matters-influenza-vaccination-response-in-ms-patients-on-ofatumumab/32826/Proactive Adverse Effect Management in mCRC: Improving Tolerability to Optimize Patient Outcomes
https://reachmd.com/programs/cme/ProactiveAdverseEffectManagementinmCRCImprovingTolerabilitytoOptimizePatientOutcomes/32945/Explore expert recommendations for optimizing clinical outcomes with targeted treatment combinations in BRAF-mutant mCRC.Patient-Centered Insights for Advanced Prostate Cancer Treatment
https://reachmd.com/programs/frontlines-prostate-cancer/patient-centered-insights-for-advanced-prostate-cancer-treatment/32211/Personalizing treatment for advanced prostate cancer patients is key to maintaining quality of life. Hear expert recommendations on creating a care plan.